AG MEDNET

AG Mednet’s technology solves critical problems for the pharmaceutical, biotechnology and medical device markets. As the leading partner for endpoint/adverse event adjudication and imaging data management, we work with the world’s top bio-pharmaceutical companies and CROs. AG Mednet has more than 60,000 registered users in 80 countries. The company has been awarded more than 1,500 clinical trials, has been chosen to manage more than 50,000 endpoints and events, and processes more than 17,000,000 images per month.